CAS: 62510-56-9; 3-(4-Chlorophenyl)-5-Cyclopropyl-2-Methylpyrrolidine

该化合物是一种丙烯衍生物,其基质为三点的氯苯替代物,五点的环丙基组,这种结构配置具有独特的消毒和电子特性,使其成为制药和农用化学合成中有价值的中间体.氯苯基组的存在会增强亲脂性和潜在的生物活动,而环丙基细胞会有助于符合僵化性.二点的甲基替代会进一步影响回作用性和选择性.这种化合物对于开发有针对性的小分子抑制剂和生物活性剂特别有用,为药用化学应用提供多种用途.高纯度等级能确保研究和工业过程的一贯性能.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-8598153-B2
      优先权日:2006-09-22
      标题 :Method of treatment using fatty acid synthesis inhibitors
      发明人:SINGH SHEO B; TOTA MICHAEL R; WANG JUN
      权利人:SINGH SHEO B; TOTA MICHAEL R; WANG JUN; MERCK SHARP & DOHME
      摘要:The present invention relates to natural products that possess fatty acid synthesis inhibitor activity and can be used to treat and prevent diseases such as obesity, cancer, diabetes, fungal infections, Mycobacterium tuberculosis infections, malarial infections and other apicomplexan protozoal diseases.

      专利号:US-10968192-B2
      优先权日:2018-09-26
      标题:Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis
      发明人:BEDNARZ MARK STEPHEN; Dai Kuangchu; ECKERT JEFFREY MANNING; LIM NGIAP-KIE; SIROIS LAUREN; WU WENXUE; ZHAO MATTHEW MANGZHU
      权利人:LEXICON PHARMACEUTICALS INC
      摘要:Methods of preparing, and solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2H-pyran-2-yl)benzyl)phenyl)butanamide, and salts, solvates and cocrystals thereof, are disclosed.

      专利号:US-2020255394-A1
      优先权日:2018-09-26
      标题 :Crystalline solid forms of n-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(2-methyl-5-((2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl)phenyl)butanamide and methods of their synthesis

      专利号:WO-2020068661-A1
      优先权日:2018-09-26
      标题:Crystalline forms of n-(1 -((2-(dimethylamino)ethyl)amino)-2-m ethyl-1 -oopropan-2-yl)-4-(4-(2-methyl-5- (2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl) phenl)butanamide and methods of their synthesis

      专利号:CA-3113037-A1
      优先权日:2018-09-26
      标 题 :Crystalline forms of n-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oopropan-2-yl)-4-(4-(2-methyl-5-(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-(methylthio)tetrahydro-2h-pyran-2-yl)benzyl)phenl)butanamide and methods of their synthesis

      专利号:AU-2007300627-A1
      优先权日:2006-09-22
      标题:Method of treatment using fatty acid synthesis inhibitors

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知